PFIZERNSEPfizer Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Tue, 12 May, 2026 · 19:52 IST

Pfizer Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

PFIZER · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.6%Reaction day
₹4725.00
prior close
₹4651.70
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.3%-1.9% vs market
Pharmaceuticals peers, median of 162sector+0.0%-1.6% vs sector

On the reaction day the stock moved 1.9 pts less than Nifty Smallcap 250 and 1.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.8
10m
+1.0
15m
+1.2
30m
+0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.6+0.3-1.9+0.0-1.6
Next day
-1.5+0.3-1.8+0.5-2.0
2d
+2.7-0.1+2.8+0.0+2.7
3d
+2.9-1.6+4.4-0.6+3.5
4d
+1.2-0.4+1.6-0.1+1.2
5d
-1.0-0.3-0.6+1.0-1.9
1w
-1.4+0.2-1.6+0.8-2.2
15d
-6.3+1.9-8.2+1.1-7.5
1m
-4.3+3.3-7.7+2.6-7.0
2m
+0.2+8.6-8.4+6.8-6.6
3m
+5.4+9.7-4.3+9.2-3.7
UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 162Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Pfizer Limited reported revenue from operations of ₹2,519.65 crore for FY2026, up 10.4% from ₹2,281.35 crore in the previous year. However, net profit declined 5.9% to ₹722.43 crore from ₹767.60 crore, impacted by exceptional items of ₹49.16 crore (personnel separation costs of ₹41.73 crore due to Cipla distribution agreement and ₹7.43 crore for new labour code provisions). EPS stood at ₹157.92 versus ₹167.79 in FY2025. The company declared an unmodified audit opinion and recommended a final dividend of ₹75 per share (750%). Operating cash flow remained strong at ₹967.57 crore.

Likely market impact

Revenue growth was moderate at 10.4%, but profit declined due to one-time restructuring charges. The clean audit opinion and strong cash flow are positives for shareholders. The ₹75 dividend signals confidence despite lower profitability.